INCON CO., LTD. received a stock award from ZYVERSA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 12/16/2022ACC: 0001493152-22-035808
10% Owner
Since Dec 2022
+1.95M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
1.95M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+1.50M
Price / share
—
Trade value
—
% of position
New position
12/12/2022
0.00→1.50M
Total
Net shares
+1.50M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/12/2022 | A · Award | +1.50M | — | — | New position | 0.00 | 1.50M |
| Total | +1.50M | $0.00 | ||||||
Derivative Transactions1
Warrant (right to buy)
Direct
Converts to
Common Stock
450.70K shares
Shares
+450.70K
Strike price
6.90
Held after
450.70K
Exercisable
—
12/12/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrant (right to buy) Direct | Common Stock450.70K shares | 12/12/2022 | A · Award | +450.70K | 6.90 | — | 450.70K |